​

Labcorp Holdings (LH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Labcorp Holdings Revenue Highlights

Latest Revenue (Y)

$12.16B

Latest Revenue (Q)

$3.56B

Main Segment (Y)

LabCorp Diagnostics

Main Geography (Y)

North America

Labcorp Holdings Revenue by Period

Labcorp Holdings Revenue by Year

DateRevenueChange
2023-12-31$12.16B-18.25%
2022-12-31$14.88B-7.72%
2021-12-31$16.12B15.33%
2020-12-31$13.98B20.98%
2019-12-31$11.55B1.95%
2018-12-31$11.33B8.54%
2017-12-31$10.44B8.29%
2016-12-31$9.64B11.08%
2015-12-31$8.68B44.39%
2014-12-31$6.01B3.50%
2013-12-31$5.81B2.41%
2012-12-31$5.67B2.33%
2011-12-31$5.54B10.76%
2010-12-31$5.00B6.59%
2009-12-31$4.69B4.21%
2008-12-31$4.51B10.74%
2007-12-31$4.07B13.30%
2006-12-31$3.59B7.91%
2005-12-31$3.33B7.87%
2004-12-31$3.08B4.95%
2003-12-31$2.94B17.21%
2002-12-31$2.51B14.00%
2001-12-31$2.20B14.61%
2000-12-31$1.92B12.99%
1999-12-31$1.70B5.34%
1998-12-31$1.61B6.16%
1997-12-31$1.52B-5.52%
1996-12-31$1.61B12.27%
1995-12-31$1.43B64.13%
1994-12-31$872.50M14.73%
1993-12-31$760.50M-

Labcorp Holdings generated $12.16B in revenue during NA 2023, up -18.25% compared to the previous quarter, and up 107.31% compared to the same period a year ago.

Labcorp Holdings Revenue by Quarter

DateRevenueChange
2025-09-30$3.56B1.03%
2025-06-30$3.53B5.45%
2025-03-31$3.35B0.47%
2024-12-31$3.33B1.44%
2024-09-30$3.28B1.90%
2024-06-30$3.22B1.39%
2024-03-31$3.18B4.72%
2023-12-31$3.03B-0.77%
2023-09-30$3.06B0.76%
2023-06-30$3.03B-0.13%
2023-03-31$3.04B-17.32%
2022-12-31$3.67B28.16%
2022-09-30$2.87B-1.92%
2022-06-30$2.92B-25.04%
2022-03-31$3.90B-3.86%
2021-12-31$4.06B-0.16%
2021-09-30$4.06B5.78%
2021-06-30$3.84B-7.71%
2021-03-31$4.16B-7.31%
2020-12-31$4.49B15.24%
2020-09-30$3.90B40.71%
2020-06-30$2.77B-1.95%
2020-03-31$2.82B-4.39%
2019-12-31$2.95B0.85%
2019-09-30$2.93B1.62%
2019-06-30$2.88B3.24%
2019-03-31$2.79B0.13%
2018-12-31$2.79B-1.55%
2018-09-30$2.83B-1.22%
2018-06-30$2.87B0.63%
2018-03-31$2.85B1.86%
2017-12-31$2.80B5.31%
2017-09-30$2.66B4.42%
2017-06-30$2.54B3.92%
2017-03-31$2.45B0.77%
2016-12-31$2.43B0.57%
2016-09-30$2.41B-0.66%
2016-06-30$2.43B2.65%
2016-03-31$2.37B2.19%
2015-09-30$2.32B2.12%
2015-06-30$2.27B26.54%
2015-03-31$1.79B18.54%
2014-12-31$1.51B-2.52%
2014-09-30$1.55B2.33%
2014-06-30$1.52B5.99%
2014-03-31$1.43B-0.44%
2013-12-31$1.44B-1.72%
2013-09-30$1.46B-0.41%
2013-06-30$1.47B1.89%
2013-03-31$1.44B2.53%
2012-12-31$1.41B-0.99%
2012-09-30$1.42B-0.28%
2012-06-30$1.42B0.01%
2012-03-31$1.42B4.19%
2011-12-31$1.37B-2.73%
2011-09-30$1.40B0.09%
2011-06-30$1.40B2.55%
2011-03-31$1.37B5.64%
2010-12-31$1.30B1.48%
2010-09-30$1.28B3.08%
2010-06-30$1.24B3.75%
2010-03-31$1.19B2.45%
2009-12-31$1.17B-1.69%
2009-09-30$1.19B-0.31%
2009-06-30$1.19B2.86%
2009-03-31$1.16B3.27%
2008-12-31$1.12B-1.41%
2008-09-30$1.14B-1.11%
2008-06-30$1.15B4.04%
2008-03-31$1.10B9.68%
2007-12-31$1.01B-

Labcorp Holdings generated $3.56B in revenue during Q3 2025, up 1.03% compared to the previous quarter, and up 110.64% compared to the same period a year ago.

Labcorp Holdings Revenue Breakdown

Labcorp Holdings Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 22Dec 21Dec 19Dec 18
LabCorp Diagnostics$10.14B$7.00B$7.03B--
Drug Development-$5.71B$11.69B--
Diagnostics-$9.20B$20.73B--
Covance Drug Development---$4.58B$4.31B

Labcorp Holdings's latest annual revenue breakdown by segment (product or service), as of Dec 24: LabCorp Diagnostics (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
LabCorp Diagnostics$2.77B$2.75B$2.63B$2.59B$2.55B$2.52B$2.48B---
Covance Drug Development----$737.70M$707.00M$710.90M---
Diagnostics------$2.48B$9.42B$2.34B$2.34B
Drug Development------$710.90M$2.77B$719.10M$699.00M

Labcorp Holdings's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: LabCorp Diagnostics (100.00%).

Labcorp Holdings Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20Dec 19Dec 18
North America$13.09B$11.53B--
Europe$2.05B$1.51B--
Other countries$976.40M$941.00M$1.20B$1.18B

Labcorp Holdings's latest annual revenue breakdown by geography, as of Dec 21: North America (81.22%), Europe (12.72%), and Other countries (6.06%).

Quarterly Revenue by Country

CountrySep 25Jun 25Mar 25Sep 24Jun 24Mar 24Sep 23Jun 23Dec 21
UNITED STATES$2.97B$2.93B$2.81B$2.74B$2.70B$2.65B$2.55B$2.54B-
North America--------$13.09B
Other countries--------$976.40M
Europe--------$2.05B

Labcorp Holdings's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (100.00%).

Labcorp Holdings Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LHLabcorp$12.16B$3.56B
DGXQuest Diagnostics$9.87B$2.82B
BIIBBiogen$9.68B$2.53B
STESTERIS$5.46B$1.39B
ILMNIllumina$4.37B$1.08B
INCYIncyte$4.24B$1.37B
DXCMDexCom$3.62B$1.21B
WATWaters$2.96B$799.89M
WSTWest Pharmaceutical Services$2.89B$804.70M
UTHRUnited Therapeutics$2.88B$799.50M
ZBHZimmer Biomet$2.02B$2.00B

LH Revenue FAQ

What is Labcorp Holdings’s yearly revenue?

Labcorp Holdings's yearly revenue for 2023 was $12.16B, representing a decrease of -18.25% compared to 2022. The company's yearly revenue for 2022 was $14.88B, representing a decrease of -7.72% compared to 2021. LH's yearly revenue for 2021 was $16.12B, representing an increase of 15.33% compared to 2020.

What is Labcorp Holdings’s quarterly revenue?

Labcorp Holdings's quarterly revenue for Q3 2025 was $3.56B, a 1.03% increase from the previous quarter (Q2 2025), and a 8.58% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $3.53B, a 5.45% increase from the previous quarter (Q1 2025), and a 9.51% increase year-over-year (Q2 2024). LH's quarterly revenue for Q1 2025 was $3.35B, a 0.47% increase from the previous quarter (Q4 2024), and a 5.30% increase year-over-year (Q1 2024).

What is Labcorp Holdings’s revenue growth rate?

Labcorp Holdings's revenue growth rate for the last 3 years (2021-2023) was -24.56%, and for the last 5 years (2019-2023) was 5.25%.

What are Labcorp Holdings’s revenue streams?

Labcorp Holdings's revenue streams in c 24 are LabCorp Diagnostics

What is Labcorp Holdings’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Labcorp Holdings was LabCorp Diagnostics. This segment made a revenue of $10.14B, representing 100.00% of the company's total revenue.